Prescription-drug policy: Don’t throw the bed out with bedpan

According to IQVIA, a health-care data firm, generic prescription drugs saved Kentucky $5.7 billion in 2017, $3.2 billion of which were savings reaped by the commonwealth’s Medicare and Medicaid programs. However, legislation (S. 64) being considered by the U.S. Senate would delay Kentucky patients access the more-affordable generic and biosimilar drugs being developed today. In…